Skip to content
CancerIndex

Publication

Psychometric evaluation of the PROMIS® Medication Adherence Scale among patients prescribed oral anticancer medication for multiple myeloma.

Sarah M Belcher, Paul Scott, Susan M Sereika, Catherine Bender, Jacqueline Dunbar-Jacob, Margaret Q Rosenzweig, Benyam Muluneh, Lindsay M Sabik, Valire Copeland, Mounzer Agha, Abigail A Lustyik, Emily S He, Corrine Bozich, Grace Booze, Petra Duran Basso, J Devin Peipert

Journal of patient-reported outcomesSep 19, 2026PMID 42791413doi:10.1186/s41687-026-01204-z PMC13615244Journal ArticleObservational StudypubmedProvenance
Source
PubMed
Retrieved
Sep 30, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260930-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

BACKGROUND: Oral anticancer medications are standard care for cancer. Medication adherence influences health outcomes, but valid, reliable measures assessing self-reported medication adherence are limited. Psychometric properties of the PROMIS® Medication Adherence Scale (PMAS) were evaluated in…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.